The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells

被引：0
|
作者：
Yong He
Xiao-mei Yuan
Ping Lei
Sha Wu
Wei Xing
Xiao-li Lan
Hui-fen Zhu
Tao Huang
Guo-bing Wang
Rui An
Yong-xue Zhang
Guan-xin Shen
机构：
[1] Hubei Key Laboratory of Molecular Imaging,Department of Nuclear Medicine
[2] Union hospital of Tongji Medical College,Department of Immunology
[3] Huazhong University of Science and Technology,Department of Surgery
[4] Tongji Medical College,undefined
[5] Huazhong University of Science and Technology,undefined
[6] Union Hospital of Tongji Medical College,undefined
[7] Huazhong University of Science and Technology,undefined
[8] Southern Medical University,undefined
[9] Yong HE and Xiao-mei YUAN contributed equally to this work.,undefined
来源：
Acta Pharmacologica Sinica | 2009年 / 30卷
关键词：
somatostatin; somatostatin receptor; epidermal growth factor receptor; breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1053 / 1059
页数：6
相关论文
共 50 条
  • [31] Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells
    Alshafie, Walaa
    Pan, Yingzhou Edward
    Kreienkamp, Hans-Juergen
    Stroh, Thomas
    ENDOCRINE, 2020, 69 (03) : 655 - 669
  • [32] Somatostatin Receptor Subtype 2 Expression and Somatostatin Receptor Scintigraphy Positivity in Pancreatic Serous Cystadenomas
    Pote, Nicolas
    Lebtahi, Rachida
    Hentic, Olivia
    Speisky, Daniela
    Sauvanet, Alain
    Vullierme, Marie-Pierre
    Bedossa, Pierre
    Ruszniewski, Philippe
    Couvelard, Anne
    PANCREAS, 2015, 44 (04) : 672 - 674
  • [33] Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells
    Walaa Alshafie
    Yingzhou Edward Pan
    Hans-Jürgen Kreienkamp
    Thomas Stroh
    Endocrine, 2020, 69 : 655 - 669
  • [34] Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs
    L. E. A. Wildemberg
    L. V. Neto
    D. F. Costa
    L. E. Nasciuti
    C. M. Takiya
    L. M. Alves
    A. Rebora
    F. Minuto
    D. Ferone
    M. R. Gadelha
    Journal of Endocrinological Investigation, 2013, 36 : 38 - 43
  • [35] Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs
    Wildemberg, L. E. A.
    Neto, L. V.
    Costa, D. F.
    Nasciuti, L. E.
    Takiya, C. M.
    Alves, L. M.
    Rebora, A.
    Minuto, F.
    Ferone, D.
    Gadelha, M. R.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (01): : 38 - 43
  • [36] In vitro apoptotic and antiproliferative effects of propranolol on human breast cancer cells
    Alizade, Ares
    Terzi, Menderes Yusuf
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2024, 62 (05) : 326 - 331
  • [37] Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells
    Soprano, Maria
    Sorriento, Daniela
    Rusciano, Maria Rosaria
    Maione, Angela Serena
    Limite, Gennaro
    Forestieri, Pietro
    D'Angelo, Dario
    D'Alessio, Matteo
    Campiglia, Pietro
    Formisano, Pietro
    Iaccarino, Guido
    Bianco, Roberto
    Illario, Maddalena
    PLOS ONE, 2016, 11 (06):
  • [38] Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells
    Qin Pan Ding-Guo Li Han-Ming Lu Yu-Qin Wang Qin-Fang Xu Department of Gastroenterology
    World Journal of Gastroenterology, 2004, (07) : 1015 - 1018
  • [39] Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells
    Pan, Qin
    Li, Ding-Guo
    Lu, Han-Ming
    Lu, Liang-Yong
    Wang, Yu-Qin
    Xu, Qin-Fang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (07) : 1015 - 1018
  • [40] Antiproliferative effect of somatostatin: transduction of the antiproliferative signal by receptor subtypes
    Susini, C
    ANNALES D ENDOCRINOLOGIE, 1998, 59 : 16 - 18
12345